Transarterial Chemoembolization with Drug-eluting Beads Preloaded with Irinotecan as a First-Line Approach in Uveal Melanoma Liver Metastases: Tumor Response and Predictive Value of Diffusion-weighted MR Imaging in Five Patients
Authors:
- Massimo VenturiniMVMassimo Venturini
- Lorenzo PillaLPLorenzo Pilla
- Giulia AgostiniGAGiulia Agostini
- Stefano CappioSCStefano Cappio
- Claudio LosioCLClaudio Losio
- Marcello OrsiMOMarcello Orsi
- Francesca RattiFRFrancesca Ratti
- Luca AldrighettiLALuca Aldrighetti
- Francesco De CobelliFCFrancesco De Cobelli
- Alessandro Del MaschioAMAlessandro Del Maschio
- 1 July 2012
- journal article
- clinical trial
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 23 (7) , 937-941
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Radioembolization as Salvage Therapy for Hepatic Metastasis of Uveal Melanoma: A Single-Institution ExperienceAmerican Journal of Roentgenology, 2011
- Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast CancerRadiology, 2010
- Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional RegistryCardioVascular and Interventional Radiology, 2010
- Transarterial chemoembolization of liver metastases in patients with uveal melanomaEuropean Journal of Radiology, 2010
- Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional RegistryJournal of Oncology, 2009
- Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patientsMelanoma Research, 2008
- Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous MelanomaAnnals of Surgical Oncology, 2008
- Irinotecan drug eluting beads for use in chemoembolization: In vitro and in vivo evaluation of drug release propertiesEuropean Journal of Pharmaceutical Sciences, 2007
- A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumoursAnnals of Oncology, 2006
- Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patientsAnnals of Oncology, 2006